SEC FORM 4
$252,875.00
Damora Therapeutics, Inc. (DMRA)
Purchase of 12,500 shares at $20.23 per share.
Reporting Person Jarrett Jennifer · Officer Title Director, President and CEO · Transaction Code P
Traded Sep 25, 2026 · Disclosed Sep 28, 2026
Source: SEC Form 4 · 0001193125-26-403355 · filed 2026-09-28 · View filing →